Company registration number 07661373 (England and Wales)
INFUSE TECHNOLOGY LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
INFUSE TECHNOLOGY LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 8
INFUSE TECHNOLOGY LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
5
7,181
8,534
Tangible assets
6
26,396
16,602
33,577
25,136
Current assets
Stocks
37,596
18,187
Debtors
7
445,197
589,626
Cash at bank and in hand
561,237
292,772
1,044,030
900,585
Creditors: amounts falling due within one year
8
(728,885)
(702,217)
Net current assets
315,145
198,368
Total assets less current liabilities
348,722
223,504
Provisions for liabilities
(6,168)
-
Net assets
342,554
223,504
Capital and reserves
Called up share capital
10
1
1
Profit and loss reserves
342,553
223,503
Total equity
342,554
223,504

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 22 December 2025 and are signed on its behalf by:
Mr J Bagley
Director
Company registration number 07661373 (England and Wales)
INFUSE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
1
Accounting policies
Company information

Infuse Technology Limited is a private company limited by shares incorporated in England and Wales. The registered office is Prospect House, 1 Prospect Place, Pride Park, Derby, United Kingdom, DE24 8HG.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

 

The Directors remain confident that the company is well placed to mitigate any additional risks arising. The Directors believe strong cash reserves held and additional funding available to the company are sufficient to provide additional levels of risk mitigation such that the Directors are confident that current economy will not adversely affect the on-going viability of the company.

1.2
Going concern

The directors have prepared budgets and cashflow forecasts to March 2026 on an individual and group level and up to date management accounts and consider that the group will continue to operate within its overdraft facility for 12 months from the date of signing the Balance Sheet. The overdraft facility has now been renewed until November 2026.true

 

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover represents net invoiced sales of goods and services, excluding value added tax.

 

Sale of goods

Turnover from the sale of goods is recognised when significant risks and rewards of ownership of the goods have transferred to the buyer, the amount of turnover can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transaction can be measured reliably. This is usually on the dispatch of the goods.

 

Rendering of services

When the outcome of a transaction can be estimated reliably, turnover from IT support services is recognised by referenced to the stage of completion at the balance sheet date. Stage of completion is measured by reference to the extent of which the services have been supplied.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

INFUSE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 3 -

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Website
straight line over 10 years
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
straight line over 6-7 years
Computers
straight line over 2-12 years, reducing balance over 2-4 years

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Stocks

Stock is valued at the lower of cost and net realisable value.

 

Cost includes all direct expenditure and an appropriate proportion of fixed and variable overheads.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Debtors and creditors receivable/payable within one year

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account.

Loans and borrowings

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

INFUSE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.11
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
23
20
4
Directors' remuneration and dividends
2025
2024
£
£
Remuneration paid to directors
100,358
98,790
Dividends paid to directors
22,500
42,750
INFUSE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
4
Directors' remuneration and dividends
(Continued)
- 5 -

The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 1 (2024 - 1).

5
Intangible fixed assets
Goodwill
Website
Total
£
£
£
Cost
At 1 April 2024 and 31 March 2025
89,794
15,195
104,989
Amortisation and impairment
At 1 April 2024
89,794
6,661
96,455
Amortisation charged for the year
-
0
1,353
1,353
At 31 March 2025
89,794
8,014
97,808
Carrying amount
At 31 March 2025
-
0
7,181
7,181
At 31 March 2024
-
0
8,534
8,534
6
Tangible fixed assets
Plant and equipment
Computers
Total
£
£
£
Cost
At 1 April 2024
11,823
57,760
69,583
Additions
-
0
23,460
23,460
Disposals
(8,452)
(26,209)
(34,661)
At 31 March 2025
3,371
55,011
58,382
Depreciation and impairment
At 1 April 2024
7,014
45,967
52,981
Depreciation charged in the year
626
10,239
10,865
Eliminated in respect of disposals
(6,589)
(25,271)
(31,860)
At 31 March 2025
1,051
30,935
31,986
Carrying amount
At 31 March 2025
2,320
24,076
26,396
At 31 March 2024
4,809
11,793
16,602
INFUSE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
7
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
319,772
480,422
Amounts owed by group undertakings
3,490
3,933
Other debtors
121,935
105,271
445,197
589,626
8
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
198,850
210,421
Amounts owed to group undertakings
2,720
2,486
Corporation tax
100,230
100,558
Other taxation and social security
110,796
105,988
Other creditors
316,289
282,764
728,885
702,217
9
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
6,168
-
2025
Movements in the year:
£
Liability at 1 April 2024
-
Charge to profit or loss
6,168
Liability at 31 March 2025
6,168

The deferred tax liability set out above is expected to reverse within 12 months and relates to accelerated capital allowances that are expected to mature within the same period.

INFUSE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
10
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary Share of 1p each
60
100
0.60
1.00
Ordinary B share of 1p each
69
29
0.69
0.29
129
129
1.29
1.29
11
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion the financial statements:

Senior Statutory Auditor:
Daniel Sowden
Statutory Auditor:
BHP LLP
Date of audit report:
22 December 2025
12
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
35,178
-
0
13
Related Party Disclosures

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

14
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

INFUSE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
14
Related party transactions
(Continued)
- 8 -
Sales
Sales
Purchases
Purchases
2025
2024
2025
2024
£
£
£
£
Entities with control, joint control or significant influence over the company
789,239
650,850
131,925
3,122

 

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due to related parties
£
£
Entities with control, joint control or significant influence over the company
14,675
12,265

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due from related parties
£
£
Entities with control, joint control or significant influence over the company
103,084
84,678
15
Parent entity

The ultimate parent entity of Infuse Technology Limited is SHH101 LLP, a limited liability partnership incorporated in England and Wales. SHH101 LLP prepares group consolidated accounts, which includes the entity's financial statements. A copy of the consolidated statements are available from the registered office of Prospect House, 1 Prospect Place, Derby, DE24 8HG.

2025-03-312024-04-01falsefalsefalse22 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityMr J BagleyMr J FarnsworthMr David NelsonMr Dean NelsonMr Bruce MontgomeryMr P HowardMr Dean Nelson076613732024-04-012025-03-31076613732025-03-31076613732024-03-3107661373core:Goodwill2025-03-3107661373core:ComputerSoftware2025-03-3107661373core:Goodwill2024-03-3107661373core:ComputerSoftware2024-03-3107661373core:PlantMachinery2025-03-3107661373core:ComputerEquipment2025-03-3107661373core:PlantMachinery2024-03-3107661373core:ComputerEquipment2024-03-3107661373core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3107661373core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3107661373core:CurrentFinancialInstruments2025-03-3107661373core:CurrentFinancialInstruments2024-03-3107661373core:ShareCapital2025-03-3107661373core:ShareCapital2024-03-3107661373core:RetainedEarningsAccumulatedLosses2025-03-3107661373core:RetainedEarningsAccumulatedLosses2024-03-3107661373bus:Director12024-04-012025-03-3107661373core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107661373core:ComputerSoftware2024-04-012025-03-3107661373core:PlantMachinery2024-04-012025-03-3107661373core:ComputerEquipment2024-04-012025-03-31076613732023-04-012024-03-3107661373core:Goodwill2024-03-3107661373core:ComputerSoftware2024-03-31076613732024-03-3107661373core:Goodwill2024-04-012025-03-3107661373core:PlantMachinery2024-03-3107661373core:ComputerEquipment2024-03-3107661373bus:OrdinaryShareClass12024-04-012025-03-3107661373bus:OrdinaryShareClass22024-04-012025-03-3107661373bus:OrdinaryShareClass12025-03-3107661373bus:OrdinaryShareClass12024-03-3107661373bus:OrdinaryShareClass22025-03-3107661373bus:OrdinaryShareClass22024-03-3107661373bus:AllOrdinaryShares2025-03-3107661373bus:AllOrdinaryShares2024-03-3107661373core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntitycore:SaleOrPurchaseGoods2024-04-012025-03-3107661373core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntitycore:SaleOrPurchaseGoods2023-04-012024-03-3107661373core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2025-03-3107661373bus:PrivateLimitedCompanyLtd2024-04-012025-03-3107661373bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107661373bus:FRS1022024-04-012025-03-3107661373bus:Audited2024-04-012025-03-3107661373bus:Director22024-04-012025-03-3107661373bus:Director32024-04-012025-03-3107661373bus:Director42024-04-012025-03-3107661373bus:Director52024-04-012025-03-3107661373bus:Director62024-04-012025-03-3107661373bus:Director72024-04-012025-03-3107661373bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP